The FDA asked for a $4.5 billion budget for fiscal 2013, up 17%, or $654 million, from this year. Industry user fees, including proposed fees for generics and biosimilars, would account for 45% of the budget and would fund 98% of the increase in spending.
FDA's proposed $4.5 billion budget heavily depends on industry fees
SmartBrief Job Listings for Health Care
|Senior Research Analyst||
America's Health Insurance Plans (AHIP)
|Manager, Regulatory Affairs||
|Washington DC, DC|
|Senior Counsel - FDA Regulatory Affairs||
|Director, Quality Assurance||
|Provider Relations Manager||
Breakthrough Behavioral, Inc.
|Redwood City, CA|